Remote Irritable Bowel Syndrome (IBS) Monitoring Global Market Report 2025
상품코드:1877871
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
원격 과민성대장증후군(IBS) 모니터링 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 12억 1,000만 달러로 평가되었고, 2025년에는 14억 달러, CAGR 16.2%로 성장할 것으로 예상되고 있습니다. 지난 몇 년간의 성장은 위장 질환의 유병률 상승, IBS 및 소화기 건강에 대한 인식 향상, 비침습적 모니터링 솔루션에 대한 수요 증가, 디지털 헬스 기술의 보급 확대, 스마트폰 및 웨어러블 디바이스의 이용 증가, 헬스케어 지출 증가, 환자 중심의 케어에 대한 주력 강화 등이 요인으로 생각됩니다.
원격 과민성대장증후군(IBS) 모니터링 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 25억 3,000만 달러에 이르고, CAGR은 15.8%를 나타낼 전망입니다. 예측 기간 중의 성장 요인으로는 소화기 모니터링용 접속 디바이스의 보급 확대, 원격 의료·온라인 진료와의 제휴 강화, 맞춤형 치료 어프로치에 대한 수요 증가, 원격 환자 모니터링 프로그램의 확충 등을 들 수 있습니다. 예측기간의 주요 동향으로는 바이오센서나 웨어러블 디바이스에 있어서의 기술적 진보, AI 기반의 증상 추적에 있어서의 혁신, 클라우드 기반의 건강 플랫폼의 진전, 장내 세균총 분석의 연구 개발, 디지털 치료법과 모바일 애플리케이션과의 통합, 예측적·실시간 모니터링을 위한 데이터 분석의 활용 등을 들 수 있습니다.
향후 몇 년 동안 원격 과민성대장증후군(IBS) 모니터링 시장의 성장을 이끌 것으로 예상되는 것은 소화기 질환의 유병률 증가입니다. 소화기 질환은 소화기계의 정상적인 기능을 방해하고 소화 및 배변 조절에 영향을 미치는 병태를 말합니다. 이러한 질병 증가는 주로 장 건강에 악영향을 미치고 염증, 복부 팽만감 및 기타 소화기계의 불쾌감을 일으키는 건강에 해로운 식습관과 관련이 있습니다. 원격 과민성대장증후군(IBS) 모니터링은 증상의 유인을 조기에 식별하고 지속적인 관리를 가능하게 함으로써 증상의 중증도 완화와 질병 진행의 지연에 기여합니다. 이것은 환자의 치료 성과를 향상시키고 삶의 질(QOL)을 향상시킵니다. 예를 들어, 2025년 2월 호주에 본사를 둔 전국 조직 "Crohn's&Colitis Australia'가 발표한 예측에 따르면, 이 나라에서의 염증성 장질환(IBD)의 유병률은 2023년 20,511,881례에서 2030년까지 23,067,771례로 증가할 것으로 전망되고 있습니다. 따라서, 소화기 질환의 발생률 증가는 원격 과민성대장증후군(IBS) 모니터링 시장의 확대에 기여합니다.
원격 과민성대장증후군(IBS) 모니터링 시장의 주요 기업들은 자사 능력을 강화하고 환자 접근을 개선하기 위해 화이트 라벨 및 공동 브랜드 서비스 모델의 도입에 주력하고 있습니다. 이러한 모델을 통해 의료 제공업체는 자체 브랜드에서 즉시 사용할 수 있는 디지털 건강 솔루션을 제공할 수 있으며, 신뢰할 수 있는 임상 정체성과 입증된 기술을 결합하여 도입 기간 단축, 비용 절감, 환자 경험 향상을 실현합니다. 예를 들어, 2024년 5월에는 미국에 본사를 둔 디지털 소화기 관리 제공업체인 Salvo Health가 만성 소화기 질환(GI) 관리를 위한 최초의 원격 환자 모니터링(RPM) 솔루션을 도입했습니다. 본 프로그램은 과민성 장 증후군(IBS), 위식도 역류증(GERD), 소화 불량, 세리악병, 소장 세균 과증식(SIBO) 등의 질환에 대해 원격 모니터링과 기존의 대면 진료를 통합한 디지털 케어 옵션을 제공합니다. Salvo는 화이트 라벨 및 공동 브랜드 모델을 통해 소화기과 의사에게 디지털 도구, 임상 직원 및 가정용 모니터링 장비를 제공하고 심박동 변동(HRV)을 추적하고 환자의 식사, 행동, 증상과 연관시켜 만성 질환 관리의 성과와 업무 효율을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 원격 과민성대장증후군(IBS) 모니터링 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 성장률 분석
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 실적 : 규모와 성장, 2019-2024
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 원격 과민성대장증후군(IBS) 모니터링 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 컴포넌트별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
디바이스
소프트웨어
서비스
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
진단
증상 추적
치료 관리
환자 교육
기타 용도
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진료소
재택치료 환경
연구기관
기타 최종 사용자
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 세분화 기기 유형별, 분석과 예측
웨어러블 모니터링 디바이스
비웨어러블형 모니터링 디바이스
휴대형 모니터링 디바이스
내장형 모니터링 디바이스
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 세분화 소프트웨어 유형별, 분석과 예측
데이터 분석 소프트웨어
모바일 헬스 용도
원격 모니터링 플랫폼
클라우드 기반 소프트웨어 솔루션
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 세분화 서비스 유형별, 분석과 예측
원격진료서비스
데이터 관리 서비스
테크니컬 서포트 서비스
연수 및 교육 서비스
제7장 지역별/국가별 분석
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 원격 과민성대장증후군(IBS) 모니터링 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
원격 과민성대장증후군(IBS) 모니터링 시장 : 경쟁 구도
원격 과민성대장증후군(IBS) 모니터링 시장 : 기업 프로파일
Indegene : 개요, 제품 및 서비스, 전략 및 재무 분석
Vivante Health : 개요, 제품 및 서비스, 전략 및 재무 분석
Thryve Health : 개요, 제품 및 서비스, 전략 및 재무 분석
Heali AI Corp. : 개요, 제품 및 서비스, 전략 및 재무 분석
Mahana Therapeutics Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
metaMe Health Inc.
Seed Health
Ayble Health
Oshi health
Salvo Health Inc.
modifyhealth Inc.
Food marble
nerva health
MyGiHealth
Sun Genomics
Dietahealth
Dige Health
Nori health
Sequenex
Bowelle
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
원격 과민성대장증후군(IBS) 모니터링 시장 2029 : 새로운 기회를 제공하는 국가
원격 과민성대장증후군(IBS) 모니터링 시장 2029 : 새로운 기회를 제공하는 부문
원격 과민성대장증후군(IBS) 모니터링 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Remote irritable bowel syndrome (IBS) monitoring refers to a digital health system that facilitates continuous observation and management of IBS symptoms. It captures real-time patient data, evaluates patterns, and generates actionable insights to support proactive healthcare decisions. This monitoring approach enhances patient engagement, enables timely interventions, and contributes to better symptom management and improved quality of life.
The main components of remote irritable bowel syndrome (IBS) monitoring include devices, software, and services. Devices comprise hardware tools and wearable technologies that help track, record, and monitor patients' digestive health and IBS symptoms. It is used across several applications such as diagnosis, symptom tracking, treatment management, patient education, and others, and serves various end users, including hospitals and clinics, homecare settings, research institutions, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The remote irritable bowel syndrome (IBS) monitoring market research report is one of a series of new reports from The Business Research Company that provides remote irritable bowel syndrome (IBS) monitoring market statistics, including remote irritable bowel syndrome (IBS) monitoring industry global market size, regional shares, competitors with a remote irritable bowel syndrome (IBS) monitoring market share, detailed remote irritable bowel syndrome (IBS) monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the remote irritable bowel syndrome (IBS) monitoring industry. The remote irritable bowel syndrome (IBS) monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The remote irritable bowel syndrome (IBS) monitoring market size has grown rapidly in recent years. It will grow from $1.21 billion in 2024 to $1.40 billion in 2025 at a compound annual growth rate (CAGR) of 16.2%. The growth during the historic period can be attributed to the rising prevalence of gastrointestinal disorders, increasing awareness of IBS and digestive health, growing demand for non-invasive monitoring solutions, wider adoption of digital health technologies, increasing use of smartphones and wearable devices, higher healthcare spending, and a stronger focus on patient-centered care.
The remote irritable bowel syndrome (IBS) monitoring market size is expected to see rapid growth in the next few years. It will grow to $2.53 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. The growth during the forecast period can be attributed to the increasing use of connected devices for gastrointestinal monitoring, greater integration with telehealth and virtual consultations, rising demand for personalized treatment approaches, and the expansion of remote patient monitoring programs. Key trends in the forecast period include technological advancements in biosensors and wearable devices, innovations in AI-based symptom tracking, progress in cloud-based health platforms, research and development in gut microbiome analysis, integration with digital therapeutics and mobile applications, and the use of data analytics for predictive and real-time monitoring.
The rising prevalence of gastrointestinal disorders is expected to drive the growth of the remote irritable bowel syndrome (IBS) monitoring market in the coming years. Gastrointestinal disorders are conditions that disrupt the normal functioning of the digestive system, affecting digestion and bowel regulation. The increase in such disorders is primarily linked to unhealthy dietary habits that negatively impact gut health, causing inflammation, bloating, and other digestive discomforts. Remote irritable bowel syndrome (IBS) monitoring helps reduce symptom severity and slow disease progression by enabling early detection of triggers and continuous management, resulting in improved patient outcomes and enhanced quality of life. For example, in February 2025, Crohn's & Colitis Australia, a national organization based in Australia, reported that the projected prevalence of inflammatory bowel disease (IBD) in the country is expected to rise from 20,511,881 cases in 2023 to 23,067,771 cases by 2030. Therefore, the growing incidence of gastrointestinal disorders is contributing to the expansion of the remote irritable bowel syndrome (IBS) monitoring market.
Leading companies in the remote irritable bowel syndrome (IBS) monitoring market are focusing on introducing white-label and co-branded service models to strengthen their capabilities and improve patient accessibility. These models enable healthcare providers to deliver ready-to-use digital health solutions under their own brand, combining trusted clinical identity with proven technology to achieve faster implementation, reduced costs, and an improved patient experience. For instance, in May 2024, Salvo Health, a US-based digital gastrointestinal care provider, introduced its first remote patient monitoring (RPM) solution for managing chronic gastrointestinal (GI) conditions. The program offers digital care options for conditions such as IBS, GERD, dyspepsia, celiac disease, and SIBO, integrating remote monitoring with traditional in-person care. Through its white-label and co-branded model, Salvo provides GI practitioners with digital tools, clinical staff, and home monitoring devices to track heart rate variability (HRV) and connect it with patient diet, behavior, and symptoms, enhancing chronic care outcomes and operational efficiency.
In March 2024, Mahana Therapeutics, a US-based company specializing in digital chronic condition management programs, acquired HiDoc Technologies GmbH for an undisclosed amount. This acquisition aims to expand Mahana Therapeutics' global footprint in digital chronic disease management, strengthen its digestive health portfolio, and improve patient outcomes through digital cognitive behavioral therapy (CBT) programs while accelerating commercialization efforts in the US and Europe. HiDoc Technologies GmbH is a Germany-based company offering remote monitoring for irritable bowel syndrome (IBS) through its digital health application, Cara Care.
Major players in the remote irritable bowel syndrome (IBS) monitoring market are Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., Seed Health, Ayble Health, Oshi health, Salvo Health Inc., modifyhealth Inc., Food marble, nerva health, MyGiHealth, Sun Genomics, Dietahealth, Dige Health, Nori health, Sequenex, and Bowelle.
North America was the largest region in the remote irritable bowel syndrome (IBS) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in remote irritable bowel syndrome (IBS) monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the remote irritable bowel syndrome (IBS) monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The remote irritable bowel syndrome (IBS) monitoring market consists of revenues earned by entities by providing services such as teleconsultations with gastroenterologists, dietary and lifestyle management guidance, digital health coaching, and patient data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The remote irritable bowel syndrome (IBS) monitoring market also includes sales of wearable gut activity monitors, smart sensors, mobile monitoring devices, and connected health tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Remote Irritable Bowel Syndrome (IBS) Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on remote irritable bowel syndrome (ibs) monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for remote irritable bowel syndrome (ibs) monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remote irritable bowel syndrome (ibs) monitoring market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Devices; Software; Services
2) By Application: Diagnosis; Symptom Tracking; Treatment Management; Patient Education; Other Applications
3) By End-User: Hospitals And Clinics; Homecare Settings; Research Institutes; Other End-Users
4. Remote Irritable Bowel Syndrome (IBS) Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Growth Analysis And Strategic Analysis Framework
5.1. Global Remote Irritable Bowel Syndrome (IBS) Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
